384 related articles for article (PubMed ID: 31261876)
1. Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia.
Łysik D; Niemirowicz-Laskowska K; Bucki R; Tokajuk G; Mystkowska J
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261876
[TBL] [Abstract][Full Text] [Related]
2. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
[TBL] [Abstract][Full Text] [Related]
3. Changes in Saliva Rheological Properties and Mucin Glycosylation in Dry Mouth.
Chaudhury NM; Shirlaw P; Pramanik R; Carpenter GH; Proctor GB
J Dent Res; 2015 Dec; 94(12):1660-7. PubMed ID: 26446936
[TBL] [Abstract][Full Text] [Related]
4. Understanding of xerostomia and strategies for the development of artificial saliva.
Kho HS
Chin J Dent Res; 2014; 17(2):75-83. PubMed ID: 25531014
[TBL] [Abstract][Full Text] [Related]
5. An update of the etiology and management of xerostomia.
Porter SR; Scully C; Hegarty AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jan; 97(1):28-46. PubMed ID: 14716254
[TBL] [Abstract][Full Text] [Related]
6. Aging-related changes in quantity and quality of saliva: Where do we stand in our understanding?
Xu F; Laguna L; Sarkar A
J Texture Stud; 2019 Feb; 50(1):27-35. PubMed ID: 30091142
[TBL] [Abstract][Full Text] [Related]
7. Rheology of saliva in health and disease.
Rereddy SK; Cao AC; Blackwell B; Poling-Skutvik R; Arratia PE; Mirza N
Biorheology; 2023; 59(1-2):19-27. PubMed ID: 35311704
[TBL] [Abstract][Full Text] [Related]
8. [Use of saliva substitutes in patients with xerostomia].
Meyer-Lueckel H; Kielbassa AM
Schweiz Monatsschr Zahnmed; 2002; 112(10):1037-58. PubMed ID: 12442709
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-induced xerostomia, pre-clinical promise of LMS-611.
Paterson C; Caldwell B; Porteous S; McLean A; Messow CM; Thomson M
Support Care Cancer; 2016 Feb; 24(2):629-636. PubMed ID: 26143037
[TBL] [Abstract][Full Text] [Related]
10. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV; Veerman EC
Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
[TBL] [Abstract][Full Text] [Related]
11. [Saliva and saliva substitutes].
van der Reijden WA; Veerman EC; van Nieuw Amerongen A
Ned Tijdschr Tandheelkd; 1993 Aug; 100(8):351-4. PubMed ID: 11913350
[TBL] [Abstract][Full Text] [Related]
12. Established and novel approaches for the management of hyposalivation and xerostomia.
Wolff A; Fox PC; Porter S; Konttinen YT
Curr Pharm Des; 2012; 18(34):5515-21. PubMed ID: 22632391
[TBL] [Abstract][Full Text] [Related]
13. On the rheological and sensory properties of a novel natural salivary substitute.
Bugarin-Castillo Y; Bou-Fadel P; Mohamed-Ismail S; Huang N; Saint-Eve A; Mathieu V; Ramaioli M
Eur J Pharm Sci; 2024 Aug; 199():106802. PubMed ID: 38763449
[TBL] [Abstract][Full Text] [Related]
14. [An electro-stimulating oral splint for dry mouth treatment].
Fedele S; Wolff A; Strietzel FP; Granizo López RM; Porter S; Konttinen YT
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):30-7, 73. PubMed ID: 19263865
[TBL] [Abstract][Full Text] [Related]
15. Lecithin-based emulsions for potential use as saliva substitutes in patients with xerostomia--viscoelastic properties.
Hanning SM; Yu T; Jones DS; Andrews GP; Kieser JA; Medlicott NJ
Int J Pharm; 2013 Nov; 456(2):560-8. PubMed ID: 23965434
[TBL] [Abstract][Full Text] [Related]
16. An ex vivo salivary lubrication system to mimic xerostomic conditions and to predict the lubricating properties of xerostomia relieving agents.
Vinke J; Kaper HJ; Vissink A; Sharma PK
Sci Rep; 2018 Jun; 8(1):9087. PubMed ID: 29904095
[TBL] [Abstract][Full Text] [Related]
17. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.
Närhi TO; Meurman JH; Ainamo A
Drugs Aging; 1999 Aug; 15(2):103-16. PubMed ID: 10495070
[TBL] [Abstract][Full Text] [Related]
18. Artificial Saliva for Therapeutic Management of Xerostomia: A Narrative Review.
Alhejoury HA; Mogharbel LF; Al-Qadhi MA; Shamlan SS; Alturki AF; Babatin WM; Mohammed Alaishan RA; Pullishery F
J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S903-S907. PubMed ID: 35017895
[TBL] [Abstract][Full Text] [Related]
19. Management of Hyposalivation and Xerostomia: Criteria for Treatment Strategies.
Epstein JB; Beier Jensen S
Compend Contin Educ Dent; 2015 Sep; 36(8):600-3. PubMed ID: 26355444
[TBL] [Abstract][Full Text] [Related]
20. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial.
Hamada T; Nakane T; Kimura T; Arisawa K; Yoneda K; Yamamoto T; Osaki T
Am J Med Sci; 1999 Sep; 318(3):146-51. PubMed ID: 10487404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
